We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
09:15 - 10:15
Poster Area
Head & neck cancer
Poster Highlights
Clinical
Motor dexterity dysfunction in NPC survivors: association with precentral gyrus dose and cisplatin exposure
Gabriel Chun-Hei Wong, China, Hong Kong Special Administrative Region
-1761
Comparison between planning MRI and contrast-enhanced planning CT for Gross Tumor Volume delineation in primary radiotherapy of Head & Neck carcinoma
Adelina Brezae, France
-2068
Pre-Treatment EBV-DNA/TLG Risk Stratification Predicts PFS/OS After Definitive Radiotherapy in Non-Metastatic Nasopharyngeal Carcinoma
Mehmet Çağrı Duymaz, Turkey
-2147
Risk Stratification of Advanced Extranodal Extension in Retropharyngeal Lymph Nodes for Nasopharyngeal Carcinoma: A Dual-Center Study
Lirong Wu, China
-2292
Pro-SPART - Proton therapy and stem cells of parotid during radiotherapy
Denis Nicolò, Italy
-2726
The impact of national consensus statements on reduction of side effects in oropharynx radiotherapy
Shona Boyle, United Kingdom
-2848
Acute side effect profiles in oropharyngeal cancer; Deep Learning-Based versus Manual IMPT Planning
Ilse van Bruggen, The Netherlands
-3024
Dose de-intensification radiotherapy after induction chemotherapy for nasopharyngeal carcinoma
Jin-Ching Lin, Taiwan, Province of China
-3036
Refining adjuvant radiation therapy decision in major salivary gland carcinoma using individualized nomogram-based prediction
Max Gau, Switzerland
-411
Outcomes of T1 Glottic Cancer Treated with Partial Laryngeal IMRT with Laryngeal Soft Tissue Matching Image Guidance
Ranjan Subramani, India
-3343
Reducing masticatory muscle doses and patient-reported trismus via implemented AI auto-segmentation-enabled dose/volume mitigation
Maria Thor, USA
-3386
Induction chemotherapy with cisplatin-docetaxel-capecitabine (PTX), followed by concurrent chemoradiotherapy in advanced nasopharyngeal carcinomas.
Hakim Belmiloud, Algeria
-3394
A 10-year survival analysis of prognostic stratification within stage III nasopharyngeal carcinoma patients based on the 9th AJCC/UICC staging system
Mei Feng, China
-3736
Longitudinal analysis of patient-reported symptom trajectories by TGFB1 genotype in head and neck cancer radiotherapy
Laia Humbert-Vidan, Spain
-3782
Prospective cohort analysis of sequential immunotherapy and hypofractionated radiotherapy in patients with head and neck squamous cell carcinoma
Viola Salvestrini, Italy
-3872
Defining predictive immune signatures by immune monitoring and machine learning from the blood of HNSCC patients in the prospective DIREKHT01 trial
Anna Donaubauer, Germany
-4065
From constraint to comfort: 2 years of H&N precision radiotherapy without a face mask.
Marion Essers, The Netherlands
-4111
Compliance to national guidelines for head and neck cancer patients with nodal involvement treated with curative radiotherapy and weekly cisplatin
Emilie Helene Kledal Overgaard, Denmark
-4117
Prognostic Impact of Pretreatment EBV-DNA Copy Number per Unit Tumor Volume in Nasopharyngeal Carcinoma Patients – A Retrospective Single-Center Study
Mehmet Varol, Turkey
-4176
target-prioritized IMRT for nasopharyngeal carcinoma abutting the spinal cord: clinical feasibility and long-term safety
YANG LI, China
-4242
Development & validation of a prospective radiomics-clinical signature for locoregional recurrence in locally advanced head and neck cancer
Hannah Mary T Thomas, India
-4315
Dosimetric predictors of one-year non-stimulated salivary function following radiotherapy for head and neck cancer
Nicole Wisener, Canada
-4396
Randomized Comparison of Simultaneous Integrated Boost (SIB-IMRT) versus Sequential IMRT in Locally Advanced Head & Neck Cancer
Debopam Purakayastha, India
-4484
Prospective analysis of social functioning and reintegration after chemoradiotherapy for nasopharyngeal carcinoma in an LMIC Setting
Nejla Fourati, Tunisia
-4496
Preferences of patients with choroidal melanoma for proton beam therapy outcomes: a discrete choice experiment
Coen Rasch, The Netherlands
-4956
First in-human experience in the TANCA-I trial (NCT06761937), adding thermotherapy to radiotherapy in locally advanced head and neck cancer patients.
Tessa Coenraad, The Netherlands
-795
Explainable machine learning model for predicting muscle loss after radiotherapy in oral cavity cancer
Jie Lee, Taiwan, Province of China
-923
Personalised prediction of occult nodal involvement in oral cavity squamous cell carcinoma using hidden Markov models
Noemi Bührer, Switzerland
-1197
Proof-of-concept multi-centre delineation study using dual-energy CT for head-and-neck cancer delineation
Anh Thu Lê, France
-1205
Correlation of post-treatment PET-CT response scores with oncologic outcomes in HNSCC: comparison of the Hopkins and Christie criteria
Mohamed Mortada Elsharief, United Kingdom
-1555
Inclusion of ipsilateral salivary gland PET/CT features improves xerostomia prediction after radiotherapy in head and neck cancer
Lucia Cubero, Spain
-1617